Yonghong Hua
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Recombinant Human Thrombopoietin Combined With Avatrombopag for Chemoradiotherapy-Induced Thrombocytopenia in Nasopharyngeal Carcinoma: A Prospective, Randomized Controlled Trial.
Journal: British journal of hospital medicine (London, England : 2005)
Published: September 25, 2025
Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 05, 2025
Concurrent chemotherapy for older patients with locoregionally advanced nasopharyngeal carcinoma: A randomized clinical trial.
Journal: Journal of geriatric oncology
Published: December 01, 2024
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma.
Journal: Neoplasia (New York, N.Y.)
Published: October 11, 2024
Comparative dosimetric analysis of normal brain tissue in patients with Nasopharyngeal carcinoma at different stages after radiation therapy.
Journal: Oral oncology
Published: June 29, 2024
Mecapegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study.
Journal: Head & neck
Published: April 08, 2024
Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma.
Journal: Cancer science
Published: February 24, 2024
Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 02, 2023
Specific-CT brain template construction and retrospective dosimetric comparison study in brain for nasopharyngeal carcinoma patients treated with IMRT or VMAT.
Journal: American journal of cancer research
Published: October 16, 2023
Anti-PD-1 Monoclonal Antibody Combined With Anti-VEGF Agent Is Safe and Effective in Patients With Recurrent/Metastatic Head and Neck Squamous Cancer as Second-Line or Beyond Treatment.
Journal: Frontiers in oncology
Published: September 22, 2021
Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR.
Journal: Frontiers in oncology
Published: August 23, 2021
Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study.
Journal: Cancer management and research
Published: May 28, 2021
Last Updated: 09/26/2026